UCB SA (UCB.BR)

EUR 187.45

(0.83%)

Operating Income Summary of UCB SA

  • UCB SA's latest annual operating income in 2023 was 604 Million EUR , down -30.25% from previous year.
  • UCB SA's latest quarterly operating income in 2024 Q2 was 323 Million EUR , down 0.0% from previous quarter.
  • UCB SA reported an annual operating income of 400 Million EUR in 2022, down -65.13% from previous year.
  • UCB SA reported an annual operating income of 1.14 Billion EUR in 2021, up 17.4% from previous year.
  • UCB SA reported a quarterly operating income of 479 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • UCB SA reported a quarterly operating income of 279 Million EUR for 2023 FY, down -30.25% from previous quarter.

Annual Operating Income Chart of UCB SA (2023 - 2002)

Historical Annual Operating Income of UCB SA (2023 - 2002)

Year Operating Income Operating Income Growth
2023 604 Million EUR -30.25%
2022 400 Million EUR -65.13%
2021 1.14 Billion EUR 17.4%
2020 977 Million EUR -9.87%
2019 1.08 Billion EUR -2.52%
2018 1.11 Billion EUR 3.44%
2017 1.07 Billion EUR 35.05%
2016 796 Million EUR 37.95%
2015 577 Million EUR 51.84%
2014 380 Million EUR 24.18%
2013 306 Million EUR -21.34%
2012 389 Million EUR 13.08%
2011 344 Million EUR 68.63%
2010 204 Million EUR -75.63%
2009 837 Million EUR 640.71%
2008 113 Million EUR -67.15%
2007 344 Million EUR -39.75%
2006 571 Million EUR 56.87%
2005 364 Million EUR -24.8%
2004 484.01 Million EUR -0.52%
2003 486.54 Million EUR -3.16%
2002 502.39 Million EUR 0.0%

Peer Operating Income Comparison of UCB SA

Name Operating Income Operating Income Difference
ABIONYX Pharma SA -3.41 Million EUR 17802.227%
ABIVAX Société Anonyme -127.37 Million EUR 574.187%
Adocia SA -17.62 Million EUR 3527.534%
Aelis Farma SA -6.46 Million EUR 9448.398%
Biophytis S.A. -14.33 Million EUR 4314.051%
Advicenne S.A. -6.45 Million EUR 9454.189%
genOway Société anonyme 2.06 Million EUR -29145.203%
IntegraGen SA -183.77 Thousand EUR 328771.709%
Medesis Pharma S.A. -4.22 Million EUR 14381.185%
Neovacs S.A. -6.9 Million EUR 8844.057%
NFL Biosciences SA -4.43 Million EUR 13733.019%
Plant Advanced Technologies SA -778.23 Thousand EUR 77711.319%
Quantum Genomics Société Anonyme -3.13 Million EUR 19352.506%
Sensorion SA -22.31 Million EUR 2807.23%
Theranexus Société Anonyme -7.64 Million EUR 8001.956%
TME Pharma N.V. -5.62 Million EUR 10839.687%
Valbiotis SA -7.16 Million EUR 8535.754%
TheraVet SA -2.17 Million EUR 27868.723%
Valerio Therapeutics Société anonyme -20.28 Million EUR 3077.129%
argenx SE -417.15 Million EUR 244.791%
BioSenic S.A. -7.04 Million EUR 8679.545%
Celyad Oncology SA -8.45 Million EUR 7242.013%
DBV Technologies S.A. -85.24 Million EUR 808.536%
Galapagos NV -88.26 Million EUR 784.318%
Genfit S.A. -26.58 Million EUR 2372.385%
GeNeuro SA -14.35 Million EUR 4306.919%
Hyloris Pharmaceuticals SA -15.99 Million EUR 3876.652%
Innate Pharma S.A. -12.66 Million EUR 4867.543%
Inventiva S.A. -102.7 Million EUR 688.069%
MaaT Pharma SA -19.94 Million EUR 3128.632%
MedinCell S.A. -20.97 Million EUR 2979.344%
Nanobiotix S.A. -26.77 Million EUR 2355.499%
Onward Medical N.V. -35.46 Million EUR 1803.184%
Oryzon Genomics S.A. -4.54 Million EUR 13377.08%
OSE Immunotherapeutics SA -22.98 Million EUR 2727.686%
Oxurion NV -12.11 Million EUR 5087.614%
Pharming Group N.V. -4.87 Million EUR 12478.206%
Poxel S.A. -28.76 Million EUR 2199.847%
GenSight Biologics S.A. -29.69 Million EUR 2133.944%
Transgene SA -30.01 Million EUR 2112.528%
Financière de Tubize SA -2.14 Million EUR 28271.983%
Valneva SE -82.08 Million EUR 835.805%
Vivoryon Therapeutics N.V. -28.83 Million EUR 2194.531%